Repeat ultrasound in pediatric EDs improves appendicitis diagnosis after referral imaging
Abstract
Background: Acute appendicitis is a leading cause of surgical emergencies in children, with ultrasound (US) emerging as a preferred diagnostic tool due to its lack of radiation and cost-effectiveness. However, the accuracy of US is highly operator-dependent and may vary between general referring emergency departments (EDs) and specialized pediatric EDs.
Objective: To compare the diagnostic sensitivity and specificity of US performed at referring EDs vs. a pediatric ED in identifying acute appendicitis.
Methods: A retrospective study analyzed pediatric patients aged <18 years who underwent US at referring EDs and were transferred to a pediatric ED for repeat imaging between July 2018 and July 2023. Data collected included US findings, surgical pathology, white blood cell count, and patient disposition. Sensitivities of the US were calculated and compared between settings.
Results: Among 64 children included, the US at the pediatric ED demonstrated higher sensitivity (85.2%) compared to referring EDs (51.9%) (p = 0.018). Pediatric ED US resulted in fewer non-visualized appendices (a 34.4% reduction) and equivocal findings (a 30.5% reduction). Patients with positive surgical pathology exhibited higher white blood cell counts (mean 17.1) and neutrophil percentages (mean 81.0%). False positive rates were low (6.9%), aligning with published benchmarks.
Conclusion: US performed at pediatric EDs exhibited superior diagnostic accuracy for appendicitis compared to referring EDs,…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.